Research programme: Notch1 modulators - Andarix Pharmaceuticals/Tulane University
Latest Information Update: 11 Apr 2016
At a glance
- Originator Tulane University
- Developer Andarix Pharmaceuticals; Tulane University
- Mechanism of Action Notch receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 20 Oct 2015 Early research in Cancer in USA (unspecified route)